title: International Association for the Study of Lung Cancer - 15th World Conference on Lung Cancer (October 27-31, 2013 - Sydney, Australia).
abstract: The 15th World Conference on Lung Cancer, organized by the International Association for the Study of Lung Cancer (IASLC), launched the association's celebration of its 40th year promoting research into lung cancer. This year's congress saw highlights from groundbreaking research in several areas, including surgery, radiation oncology, chemo-therapy, immunotherapy, imaging and screening, prevention and epidemiology, and supportive care, with a record number of delegates in attendance. This report focuses on highlights from a poster, oral and mini oral sessions covering from several tracks.
authors: Thomson Reuters, London, UK. karen.walker@thomsonreuters.com.
authors: K
authors: K
authors: Walker
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D055752:Small Cell Lung Carcinoma / Q000188:drug therapy / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents
keywords: Alisertib; BIA-6; DBPR-112; Farletuzumab; Givinostat; HM-61713B; KNG-I-484C; Lurbinectedin; OSI-906; TroVax; Volasertib